Researcher
Sandrine Aspeslagh
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Internal medicine (Department)
Member
From1 Oct 2008 → 30 Sep 2012
Projects
1 - 1 of 1
- Role of natural killer T cells in the pathophysiology and treatment of experimental arthritisFrom1 Oct 2008 → 30 Sep 2012Funding: FWO fellowships, BOF - Other initiatives
Publications
1 - 10 of 24
- A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients(2023)
Authors: Odrade Gondry, Catarina Xavier, Johannes Heemskerk, Laurens Albert J Raes, Jens Debacker, Frank De Geeter, Christel Fontaine, Marian Vanhoeij, Sandrine Aspeslagh, Sofie Joris, et al.
Number of pages: 1 - New paradigm in NKT cell antigens : MCS-0208 (2-(hydroxymethyl)phenylthio-phytoceramide) - an aryl-phytoceramide compound with a single hydroxyl group stimulates NKT cells(2021)
Authors: Roser Borras-Tuduri, Anna Alcaide, Sandrine Aspeslagh, Lorena Usero, Carmen Serra, Carme Roura-Mir, Amadeu Llebaria
Pages: 2491 - 2496 - Synthesis of C-5" and C-6"-modified U+03B1-GalCer analogues as iNKT-cell agonists(2015)
Authors: Joren Guillaume, Nora Pauwels, Sandrine Aspeslagh, Dirk Zajonc
Pages: 3175 - 3182 - An in silico approach for modelling T-helper polarizing iNKT cell agonists(2014)
Authors: Anton De Spiegeleer, Evelien Wynendaele, Matthias Vandekerckhove, Sofie Stalmans, Maxime Boucart, Nele Van Den Noortgate, Sandrine Aspeslagh
- Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells(2013)
Authors: Tine Decruy, Sandrine Aspeslagh
Pages: 2174 - 2183 - A computational high-throughput screening approach of iNKT-agonists: a novel tool to find optimized iNKT cell ligands(2013)
Authors: Anton De Spiegeleer, Evelien Wynendaele, Sofie Stalmans, Nele Van Den Noortgate, Matthias Vandekerckhove, Sandrine Aspeslagh
Number of pages: 1 - Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis(2011)
Authors: Sandrine Aspeslagh, Yali Li, Esther Dawen Yu, Nora Pauwels, Matthias Trappeniers, Enrico Girard, Tine Decruy, Michael Drennan, Luc Leybaert, Jing Wang, et al.
Pages: 2294 - 2305 - Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo(2011)Volume: 70
Authors: Sandrine Aspeslagh, YaLi Li, Esther Dawen Yu, Nora Pauwels, Matthias Trappeniers, Enrico Girardi, Tine Decruy, Katrien Van Beneden, Koen Venken, Michael Drennan, et al.
Pages: A53 - A53 - 6''-Modified alpha-GalCer analogs capable of establishing an extra interaction with Cd1d leading to a polarized Th1 response and superior tumor protection(2011)Volume: 241
Authors: Serge Van Calenbergh, Nora Pauwels, Sandrine Aspeslagh, YaLi Li, Matthias Trappeniers, Dirk Zajonc, Dirk Elewaut
Number of pages: 1 - Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid(2010)Volume: 135
Authors: Sandrine Aspeslagh, Yali Li, Tine Decruy, Katrien Van Beneden, Koen Venken, Matthias Trappeniers, Serge Van Calenbergh, Dirk Zajonc, Dirk Elewaut
Pages: S40 - S40
Patents
1 - 2 of 2